How pharma brands handled paid social during Trump’s final 2 weeks in office
Some brands that paused Twitter ads after the Capitol riot have yet to return.
Pharma
Until we meet again: Reflections from a JPMorgan Health Conference like no other
There were pluses and minuses to attending from afar.
Pharmacies take center stage at day three of JPM
Every crisis has its winners and losers, and this once-in-a-generation pandemic is no exception.
Telehealth, drug prices, vaccine rollout headline day 2 of JPMorgan Healthcare Conference
Execs from Pfizer, Sanofi and CVS Health shared company updates with the virtual throng.
Behavioral scientists propose fixes for the ailing vaccine rollout
Sacrificing equity for vaccine expediency is a bad idea, behavioral-science experts warn.
Five things for pharma marketers to know: Tuesday, January 12, 2021
Eli Lilly drug shows promise in slowing cognitive decline; Japan discovers another COVID strain; Valo Health raises $190 million to develop AI platform.
JPMorgan in the time of COVID-19: What to look out for at this year’s healthcare conference
The annual conference arrives at a moment when pharma’s reputation is riding high for the first time in recent memory.
Five things for pharma marketers to know: Monday, January 11, 2021
Arthritis drugs show promise in treating severely ill COVID-19 patients; Scorpion Therapeutics brings in $162 million in funding; UnitedHealth buys Change Healthcare
Five things for pharma marketers to know: Friday, January 8, 2021
Biopharma leaders denounce Capitol violence; Senate Democrats likely to push for health policy changes; Wednesday becomes deadliest day in pandemic
Best of 2020: Top pharma stories
MM+M’s most popular pharma stories of the year spanned features the industry’s reaction to the death of George Floyd and COVID-19, surveys on how to navigate challenges due to the pandemic and more.
